A detailed history of Sectoral Asset Management Inc transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Sectoral Asset Management Inc holds 8,500 shares of PCVX stock, worth $641,835. This represents 0.29% of its overall portfolio holdings.

Number of Shares
8,500
Previous 8,050 5.59%
Holding current value
$641,835
Previous $505,000 14.85%
% of portfolio
0.29%
Previous 0.23%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$59.79 - $81.05 $26,905 - $36,472
450 Added 5.59%
8,500 $580,000
Q4 2023

Feb 14, 2024

SELL
$45.35 - $63.41 $5.13 Million - $7.18 Million
-113,180 Reduced 93.36%
8,050 $505,000
Q3 2023

Nov 14, 2023

BUY
$46.0 - $53.1 $563,638 - $650,634
12,253 Added 11.24%
121,230 $6.18 Million
Q2 2023

Aug 11, 2023

BUY
$34.66 - $54.07 $1.7 Million - $2.65 Million
48,977 Added 81.63%
108,977 $5.44 Million
Q4 2022

Feb 10, 2023

BUY
$20.58 - $47.95 $1.23 Million - $2.88 Million
60,000 New
60,000 $2.88 Million

Others Institutions Holding PCVX

About Vaxcyte, Inc.


  • Ticker PCVX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,315,100
  • Market Cap $4.48B
  • Description
  • Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...
More about PCVX
Track This Portfolio

Track Sectoral Asset Management Inc Portfolio

Follow Sectoral Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sectoral Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Sectoral Asset Management Inc with notifications on news.